IGC Pharma (IGC) Income from Non-Controlling Interests (2010 - 2018)
IGC Pharma's Income from Non-Controlling Interests came in at $634.00 for Q4 2018, compared with -$12,449 a year earlier.
Powered by 
Analysis
IGC Pharma (IGC) Income from Non-Controlling Interests (2010 - 2018) Analysis & Trends
For FY2017, IGC Pharma's Income from Non-Controlling Interests was $14,399.
- Income from Non-Controlling Interests carries a five-year compound annual growth rate of -36.5% (FY2012 to FY2017).
- Going back by year, Income from Non-Controlling Interests was -$25,702 in FY2016, -$69,165 in FY2015, -$19,988 in FY2014 and $15,076 in FY2013 (-89.2%).
- The Q4 2018 figure represents the highest quarterly Income from Non-Controlling Interests since Q3 2017.
- Business Quant data shows IGC's Income from Non-Controlling Interests at -$230.00 (Q3 2018), -$84.00 (Q2 2018) and -$319.00 (Q1 2018) in the three quarters before Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | IGC Pharma | 27.66 Mn | 24.91 Mn | 55,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 634.00 |
| Dec 31, 2017 | -230.00 |
| Sep 30, 2017 | -84.00 |
| Jun 30, 2017 | -319.00 |
| Mar 31, 2017 | -12,449.00 |
| Dec 31, 2016 | 38,088.00 |
| Sep 30, 2016 | -5,073.00 |
| Jun 30, 2016 | 23,238.00 |
| Mar 31, 2016 | 28,298.00 |
| Dec 31, 2015 | -42,000.00 |
| Sep 30, 2015 | -16,979.00 |
| Jun 30, 2015 | 29,085.00 |
| Mar 31, 2015 | -40,118.00 |
| Dec 31, 2014 | -8,882.00 |
| Sep 30, 2014 | -28,454.00 |
| Jun 30, 2014 | -8,289.00 |
| Mar 31, 2014 | -13,660.00 |
| Dec 31, 2013 | -5,336.00 |
| Sep 30, 2013 | 181.00 |
| Jun 30, 2013 | -1,173.00 |
API Access
IGC Pharma Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();